Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.59 |
| ▸ | AKT1 | P31749 | 2/20 | 0.59 |
| ▸ | ESR1 | P03372 | 1/20 | 0.59 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.59 |
| ▸ | CDC25A | P30304 | 1/20 | 0.59 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.59 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.59 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.59 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.58 |
| ▸ | APAF1 | O14727 | 1/20 | 0.54 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.54 |
| ▸ | RAD52 | P43351 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.49 |
| ▸ | PRKCG | P05129 | 1/20 | 0.49 |
| ▸ | PRKCB | P05771 | 1/20 | 0.49 |
| ▸ | PRKCA | P17252 | 1/20 | 0.49 |
| ▸ | PRKCH | P24723 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL34468243 | 1.00 | LMNA (0.59) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL11365261 | 1.00 | LMNA (0.59) | LMNAAKT1ESR1ADORA3CDC25A | |
| Cetrimonium SCHEMBL11365068 | 1.00 | LMNA (0.59) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL11365085 | 1.00 | LMNA (0.59) | LMNAAKT1ESR1ADORA3CDC25A | |
| Phosphoric Acid Monomethyl Ester SCHEMBL15732286 | 0.90 | DNM1 (0.60) | LMNAAKT1ESR1ADORA3CDC25A | |
| Phosphoric Acid Monomethyl Ester SCHEMBL26929137 | 0.90 | DNM1 (0.60) | LMNAAKT1ESR1ADORA3CDC25A | |
| Phosphoric Acid Monomethyl Ester SCHEMBL26929150 | 0.90 | DNM1 (0.60) | LMNAAKT1ESR1ADORA3CDC25A | |
| Phosphoric Acid Monomethyl Ester SCHEMBL26929195 | 0.90 | DNM1 (0.60) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL626714 | 0.89 | LMNA (0.50) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL11362590 | 0.89 | DNM1 (0.58) | LMNAAKT1ESR1ADORA3CDC25A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12123131-B2 | Synthetic fiber processing agent and synthetic fiber | TAKEMOTO YUSHI KABUSHIKI KAISHA (JP) | 2024-10-22 | — | — | US | disclosed |
| US-20240271360-A1 | SYNTHETIC FIBER PROCESSING AGENT AND SYNTHETIC FIBER | TAKEMOTO YUSHI KABUSHIKI KAISHA (JP) | 2024-08-15 | — | — | US | disclosed |
| WO-2023238500-A1 | TREATMENT AGENT FOR CARBON FIBER PRECURSOR, AND CARBON FIBER PRECURSOR | 竹本油脂株式会社 | 2023-12-14 | — | — | WO | disclosed |
| US-20040171867-A1 | Reactive monomer composition modified by a small-amount of lactones, an acrylic polyol resin, a curable resin composition, and a coating composition | OKAZAKI AKIRA (JP) | 2004-09-02 | — | — | US | disclosed |
| US-6767987-B2 | CURABLE RESIN COMPOSITION COMPRISING ACRYLIC POLYOL RESIN INCLUDING HYDROXYALKYL(METH)ACRYLATE COMPOSITION HAVING SMALL AMOUNT OF POLYMERIZED LACTONE MONOMER, AND MELAMINE RESIN | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2004-07-27 | — | — | US | disclosed |
| US-20030149227-A1 | Lowly lactone-modified reactive monomer composition, acrylic polyol resins produced with the same, curable resin compositions and coating compositions | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2003-08-07 | — | — | US | disclosed |
| EP-1227113-A1 | LOWLY LACTONE-MODIFIED REACTIVE MONOMER COMPOSITION, ACRYLIC POLYOL RESINS PRODUCED WITH THE SAME, CURABLE RESIN COMPOSITIONS AND COATING COMPOSITIONS | DAICEL CHEMICAL INDUSTRIES, Ltd. (JP) | 2002-07-31 | — | — | EP | disclosed |
| EP-0751196-B1 | Curable resin composition, coating composition and process for forming a cured film | NIPPON PAINT CO LTD (JP) | 2000-01-05 | — | — | EP | disclosed |
| US-5932658-A | CURABLE | NIPPON PAINT CO., LTD. (JP) | 1999-08-03 | — | — | US | disclosed |
| EP-0789064-A2 | Curable resin composition, coating composition and method for forming coated film | Nippon Paint Co., Ltd. (JP) | 1997-08-13 | — | — | EP | disclosed |
| EP-0751196-A2 | Curable resin composition, coating composition and process for forming a cured film | Nippon Paint Co., Ltd. (JP) | 1997-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040171867-A1 | Reactive monomer composition modified by a small-amount of lactones, an acrylic polyol resin, a curable resin composition, and a coating composition | MSR1, FUT4, MRE11 | LMNA 181/4885AKT1 1578/4885ESR1 2135/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.